Injections without needles
Total raised: $90M
Investors 3
| Date | Name | Website |
| - | J2 Venture... | j2vp.com |
| - | Georgia Re... | gra.org |
| - | GRA Ventur... | graventure... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 16.01.2025 | Series A | $16M | - |
| 10.01.2025 | Grant | $43M | - |
| 11.05.2023 | Series A | $17M | - |
| 04.12.2022 | Series A | $14M | - |
Mentions in press and media 14
| Date | Title | Description |
| 16.01.2025 | Micron Biomedical Raises $16M; Extends Series A Financing to Over $33M | Micron Biomedical, an Atlanta, GA-based life science company developing a needle-free technology for drugs and vaccines that is based on dissolvable microarrays, raised $16m extending its Series A funding to over $33M. The latest round was ... |
| 16.01.2025 | Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines | ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Micron Biomedical, a life science company developing the world’s first needle-free technology for drugs and vaccines that is based on dissolvable microarrays, today announced it secured more than $... |
| 16.01.2025 | Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines | $16M extension round led by J2 Ventures and GHIC builds on support from BARDA, CEPI, the Bill & Melinda Gates Foundation and others to simplify access to life-saving drugs ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Micron Biomedical, a ... |
| 11.01.2025 | Micron Biomedical: Pioneering a Needle-Free Future in Vaccine Delivery | In the realm of healthcare, innovation is the lifeblood that fuels progress. Micron Biomedical is a beacon of this innovation, crafting a future where vaccines can be delivered without needles. This Atlanta-based life sciences company is on... |
| 10.01.2025 | Micron Biomedical: $43 Million In Total Grant Support Raised | Micron Biomedical, a life science company developing the world’s first needle-free technology for drugs and vaccines based on dissolvable microarrays, announced the company secured a $7.5 million grant from the Bill & Melinda Gates Foun... |
| 08.01.2025 | CEPI and Micron Biomedical Accelerate Needle-Free Vaccines against Disease X with $3.7 Million Grant to Advance Learnings from COVID-19 | OSLO, Norway and ATLANTA, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The Coalition for Epidemic Preparedness Innovations (CEPI) is awarding $3.7 million in new funding to Micron Biomedical to advance research into an innovative technology that could... |
| 16.11.2023 | Gates Foundation grants $23.6M to Micron Biomedical for needle-free vaccines | The company will use the funding to mass produce its “peel & stick” microarray technology As it stands today, the delivery of injectable vaccines and therapeutics require a great deal of infrastructure, which significantly hinders acces... |
| 11.05.2023 | USA-based Micron Biomedical raises an additional USD 3 million in Series A | Atlanta, USA-based life science company developing dissolvable microarray-based products, Micron Biomedical, raises an additional USD 3 million in Series A. The round took place on May 10, 2023. J2 Ventures led the financing for the firm. |
| 10.05.2023 | Micron Biomedical Raises Additional $3M; Extends Series A to $17M | Micron Biomedical, an Atlanta, GA-based life science company developing dissolvable microarray-based products, raised additional $3M in funding; extending its Series A to $17M. The round was led by J2 Ventures. J2 Ventures Partner and forme... |
| 10.05.2023 | Micron Biomedical Extends Series A to $17 million | ATLANTA, GA, Micron Biomedical announced it has secured an additional $3 million investment from J2 Ventures. >> Click here for more funding data on Micron Biomedical >> To export Micron Biomedical funding data to PDF and Ex... |
Show more